---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-050606"
form_type: "8-K"
ticker: "ABEO"
cik: "0000318306"
company_name: "ABEONA THERAPEUTICS INC."
filed_at: "2026-11-09T11:30:34+00:00"
generated_at: "2026-11-09T11:35:25.983681+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Abeona acquires Ellodi's APT-1011 (ABO-801) for $20M stock plus up to $60M milestones; raises $30M PIPE

## Summary
- Acquired APT-1011 (renamed ABO-801), a once-daily oral fluticasone propionate ODT for eosinophilic esophagitis; $20M paid in 4,494,383 ABEO shares, no upfront cash.
- Ellodi eligible for $30M on FDA NDA approval and up to $30M in sales milestones, plus low-to-mid-teens royalties; 4,494,383 shares locked up 1/3 at 6, 12, 18 months.
- Private placement: 6,400,000 shares at $3.75 plus pre-funded warrants for 1,600,043 shares at $3.7499, ~$30M gross; investors include Nantahala, TPG, Perceptive; Morgan Stanley agent.
- ABO-801 holds FDA Orphan Drug and Fast Track designations; two completed Phase 3 trials (361 patients) missed the co-primary symptom endpoint but showed significant endoscopic gains.
- Phase 3 trial planned to start Q2 2027, topline by end-2028; ~360,000 patients in the U.S. diagnosed with EoE.

## SEC filing metadata
- accession: 0001493152-26-050606
- form_type: 8-K
- ticker: ABEO
- cik: 0000318306
- company_name: ABEONA THERAPEUTICS INC.
- filed_at: 2026-11-09T11:30:34+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 2.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/318306/000149315226050606/0001493152-26-050606-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/318306/000149315226050606/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-050606
- JSON: https://secwatch.observer/filing/0001493152-26-050606.json
- Plain text: https://secwatch.observer/filing/0001493152-26-050606.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.